Solutions - Page 3

Amid a major corporate overhaul, Novo Nordisk is pruning the ranks at its Bloomington, Indiana, production facility, which contributes to the blockbuster GLP-1 medications Ozempic and Wegovy.

BASF Pharma Solutions will raise its prices by up to 20% for its excipients and some of its active pharmaceutical ingredients, effective immediately.

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to July 6 after the company submitted additional CMC-related data.

The labor union of Samsung Biologics has secured the votes needed to strike, signaling a potential escalation in an impasse over what the union has branded “[u]nresolved governance failures and rigid labor

The new company, looking to eliminate costly manufacturing bottlenecks by producing biologic medicines in chicken eggs, has now lined up a commercial taker.

With key expansions coming to fruition on either side of the pond, specialist CDMO Hovione is making sure that drugmakers can access its particle engineering expertise across multiple geographies.

UCB will build a new manufacturing facility near its U.S. headquarters in Atlanta, Georgia. It will become the first major manufacturing facility in the U.S. for the rapidly growing Belgium-based company and

Despite policy uncertainties in recent years, WuXi Biologics’ emphasis on its U.S. operations continued to pay off in 2025, with the States accounting for a major portion of the record number of

Wilmington PharmaTech, a CDMO specializing in churning out complex custom APIs for small molecules, will drop $50 million in a move to double the current production capacity at its Delaware facility.